[HTML][HTML] Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis …
…, A Munck, JC Davies, KM de Winter–de Groot… - Journal of Cystic …, 2021 - Elsevier
Over the past two decades there has been considerable progress with the evaluation and
management of infants with an inconclusive diagnosis following Newborn Screening (NBS) for …
management of infants with an inconclusive diagnosis following Newborn Screening (NBS) for …
[HTML][HTML] Nitric oxide in cystic fibrosis
KM de Winter-de Groot, CK van der Ent - Journal of Cystic Fibrosis, 2005 - Elsevier
Cystic fibrosis (CF) is characterized by chronic airway infection and inflammation, which
accounts for most morbidity and deaths. Exhaled nitric oxide (NO), elevated in most …
accounts for most morbidity and deaths. Exhaled nitric oxide (NO), elevated in most …
A functional CFTR assay using primary cystic fibrosis intestinal organoids
…, I Bronsveld, HM Janssens, KM De Winter-de Groot… - Nature medicine, 2013 - nature.com
We recently established conditions allowing for long-term expansion of epithelial organoids
from intestine, recapitulating essential features of the in vivo tissue architecture. Here we …
from intestine, recapitulating essential features of the in vivo tissue architecture. Here we …
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
…, HGM Heijerman, KM de Winter–de Groot… - Science translational …, 2016 - science.org
Identifying subjects with cystic fibrosis (CF) who may benefit from cystic fibrosis transmembrane
conductance regulator (CFTR)–modulating drugs is time-consuming, costly, and …
conductance regulator (CFTR)–modulating drugs is time-consuming, costly, and …
[HTML][HTML] Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes
…, C Colombo, KM de Winter-De Groot… - … England Journal of …, 2021 - Mass Medical Soc
Background Elexacaftor–tezacaftor–ivacaftor is a small-molecule cystic fibrosis transmembrane
conductance regulator (CFTR) modulator regimen shown to be efficacious in patients …
conductance regulator (CFTR) modulator regimen shown to be efficacious in patients …
Tubuloids derived from human adult kidney and urine for personalized disease modeling
…, S Derakhshan, KM de Winter-de Groot… - Nature …, 2019 - nature.com
Adult stem cell-derived organoids are three-dimensional epithelial structures that
recapitulate fundamental aspects of their organ of origin. We describe conditions for the long-term …
recapitulate fundamental aspects of their organ of origin. We describe conditions for the long-term …
[PDF][PDF] Rectal organoids enable personalized treatment of cystic fibrosis
…, E Kruisselbrink, JF Dekkers, KM de Winter-de Groot… - Cell reports, 2019 - cell.com
In vitro drug tests using patient-derived stem cell cultures offer opportunities to individually
select efficacious treatments. Here, we provide a study that demonstrates that in vitro drug …
select efficacious treatments. Here, we provide a study that demonstrates that in vitro drug …
[HTML][HTML] A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
…, A Jackson, KM de Winter-de Groot… - Journal of cystic …, 2020 - Elsevier
Abstract Information is lacking on the clinical impact of the novel coronavirus, SARS-CoV-2,
on people with cystic fibrosis (CF). Our aim was to characterise SARS-CoV-2 infection in …
on people with cystic fibrosis (CF). Our aim was to characterise SARS-CoV-2 infection in …
[PDF][PDF] CRISPR-based adenine editors correct nonsense mutations in a cystic fibrosis organoid biobank
…, P van Mourik, G Berkers, KM de Winter-de Groot… - Cell stem cell, 2020 - cell.com
Adenine base editing (ABE) enables enzymatic conversion from AT into GC base pairs. ABE
holds promise for clinical application, as it does not depend on the introduction of double-…
holds promise for clinical application, as it does not depend on the introduction of double-…
Development of the respiratory tract microbiota in cystic fibrosis
EM de Koff, KM de Winter-de Groot… - Current opinion in …, 2016 - journals.lww.com
Long-term follow-up of microbiome development and alterations in relation to progression
of lung disease and treatment is recommended. Moreover, integrating this information with …
of lung disease and treatment is recommended. Moreover, integrating this information with …